Cathelicidins positively regulate pancreatic β-cell functions.

Area of Science:

• Endocrinology
• Immunology
• Molecular Biology

Background:

• Cathelicidins are antimicrobial peptides with immunomodulatory roles.
• The function of cathelicidins in pancreatic beta cells remains largely unexplored.
• Understanding beta cell regulation is crucial for diabetes research.

Purpose of the Study:

• To investigate the expression and function of cathelicidin-related antimicrobial peptide (CRAMP) in pancreatic beta cells.
• To determine CRAMP's role in beta cell survival, insulin secretion, and inflammatory responses.
• To explore the therapeutic potential of CRAMP in models of diabetes.

Main Methods:

• Quantitative analysis of CRAMP expression in beta cell lines and islets.
• In vitro studies on beta cell survival and apoptosis modulation.
• Ex vivo assessment of glucose-stimulated insulin secretion.
• In vivo studies using CRAMP-deficient and prediabetic mouse models.

Main Results:

• CRAMP is constitutively expressed and inducible in beta cells.
• CRAMP enhances beta cell survival via EGFR and modulates Bcl-2 family proteins.
• CRAMP stimulates glucose-stimulated insulin secretion and modulates inflammatory responses.
• CRAMP deficiency impairs insulin secretion, while CRAMP administration improves glucose tolerance in vivo.

Conclusions:

• Cathelicidins, specifically CRAMP, play a significant role in regulating beta cell function and survival.
• CRAMP exhibits protective effects against inflammation-induced beta cell damage.
• CRAMP represents a potential therapeutic target for diseases involving beta cell dysfunction.